Joshua Rokach
Affiliations: | Florida Institute of Technology, Melbourne, FL, United States |
Area:
BiochemistryGoogle:
"Joshua Rokach"Mean distance: (not calculated yet)
Children
Sign in to add traineeSeongjin Kim | grad student | 2001 | Florida Institute of Technology |
Sheila M. Jacobo | grad student | 2005 | Florida Institute of Technology |
Sashikala Sivendran | grad student | 2005 | Florida Institute of Technology |
Namin Kang | grad student | 2007 | Florida Institute of Technology |
Chih-Tsung Chang | grad student | 2008 | Florida Institute of Technology |
Pranav Patel | grad student | 2008 | Florida Institute of Technology |
Vivek Gore | grad student | 2011 | Florida Institute of Technology |
Qiuji Ye | grad student | 2012-2018 | Florida Institute of Technology |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Chourey S, Wang R, Ye Q, et al. (2023) Concise Syntheses of Microsomal Metabolites of a Potent OXE (Oxoeicosanoid) Receptor Antagonist. Chemical & Pharmaceutical Bulletin. 71: 534-544 |
Cossette C, Chourey S, Ye Q, et al. (2022) Metabolism of anti-inflammatory OXE (oxoeicosanoid) receptor antagonists by nonhuman primates. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 106144 |
Cossette C, Miller LA, Ye Q, et al. (2021) Targeting the oxoeicosanoid (OXE) receptor with a selective antagonist inhibits allergen-induced pulmonary inflammation in non-human primates. British Journal of Pharmacology |
Powell WS, Rokach J. (2020) Targeting the OXE receptor as a potential novel therapy for asthma. Biochemical Pharmacology. 113930 |
Ye Q, Chourey S, Reddy CN, et al. (2019) Novel highly potent OXE receptor antagonists with prolonged plasma lifetimes that are converted to active metabolites in vivo in monkeys. British Journal of Pharmacology |
Miller LA, Cossette C, Chourey S, et al. (2019) Inhibition of allergen-induced dermal eosinophilia by an oxoeicosanoid (OXE) receptor antagonist in nonhuman primates. British Journal of Pharmacology |
Chourey S, Ye Q, Reddy CN, et al. (2018) Novel highly potent and metabolically resistant oxoeicosanoid (OXE) receptor antagonists that block the actions of the granulocyte chemoattractant 5-oxo-6,8,11,14-eicosatetraenoic acid (5-oxo-ETE). Journal of Medicinal Chemistry |
Chourey S, Ye Q, Reddy CN, et al. (2018) Corrigendum to "In vivo α-hydroxylation of a 2-alkylindole antagonist of the OXE receptor for the eosinophil chemoattractant 5-oxo-6,8,11,14-eicosatetraenoic acid in monkeys" [Biochem. Pharmacol. 138 (2017) 107-118]. Biochemical Pharmacology. 154: 174 |
Reddy CN, Alhamza H, Chourey S, et al. (2018) Metabolism and pharmacokinetics of a potent N-acylindole antagonist of the OXE receptor for the eosinophil chemoattractant 5-oxo-6,8,11,14-eicosatetraenoic acid (5-oxo-ETE) in rats and monkeys. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences |
Ye Q, Chourey S, Wang R, et al. (2017) Structure-activity relationship study of β-oxidation resistant indole-based 5-oxo-6,8,11,14-eicosatetraenoic acid (5-oxo-ETE) receptor antagonists. Bioorganic & Medicinal Chemistry Letters |